The (b)(6) 2023 aware date reflects the earliest known date of reportable information to the fda.The patient subsequently died two days following this date on (b)(6) 2023.Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that 14 years and 1 month post implant of this 21mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was reported as severe aortic regurgitation.It was reported that four days later, the patient died.The cause of death was acute on chronic combined systolic and diastolic congestive heart failure and flash pulmonary edema related to severe valvular heart disease.It was noted that the patient was experiencing severe degenerative, symptomatic bioprosthetic aortic valve stenosis with a mean gradient of 46mmhg and flow velocity of 4.3m/s.It was stated that severe aortic valvular calcification and proximal aortic root calcification were observed on computed tomography angiography (cta).
|